ATC Group: C10BA06 Rosuvastatin and ezetimibe

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C10BA06 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C10 Lipid modifying agents
3 C10B Lipid modifying agents, combinations
4 C10BA Combinations of various lipid modifying agents
5 C10BA06

Related product monographs

Document Type Information Source  
 EZEHRON DUO Tablet MPI, EU: SmPC Medicines Authority (MT)
 TWICOR Film-coated tablet MPI, EU: SmPC Medicines Authority (MT)

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Brazil (BR)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

France (FR)

Germany (DE)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.